Facile conversion of 4-endo-hydroxy-2-oxabicyclo[3.3.0]oct-7-en-3-one into carbocyclic 2′-deoxyribonucleoside analogues

Abstract

The readily available 3,5-syn-disubstituted cyclopentenes 9–13 react with N-bromosuccinimide (or N-bromoacetamide) and silver acetate in glacial acetic acid in a highly stereoselective manner to furnish the bromoacetates 14–18 in good yields. A plausible explanation for the observed selectivity is proposed. Hydrodebromination of compounds 14, 17, 18 and 19 provided the corresponding 2′-deoxyribonucleoside analogues 20–23.

References

1. cis-5-Hydroxymethylcyclopent-2-enol: R. A. MacKeith, R. McCague, H. F. Olivo, C. F. Palmer and S. M. Roberts, J. Chem. Soc., Perkin Trans. 1, 1993, 313; B. M. Trost, L. Li and S. G. Guile, J. Am. Chem. Soc., 1992, 114, 8745; F. Burlina, A. Favre, J.-L. Fourrey and M. Thomas, Bioorg. Med. Chem. Lett., 1997, 7, 247; H. R. Olivo and J. Yu, J. Chem. Soc., Perkin Trans. 1, 1998, 391; R. McCague, H. F. Olivo and S. M. Roberts, Tetrahedron Lett., 1993, 34, 3785; T. Berranger and Y. Langlois, Tetrahedron Lett., 1995, 36, 5523; M. T. Crimmins and B. W. King, J. Org. Chem., 1996, 61, 4192 cis-4-Hydroxymethylcyclopent-2-enol: H. Paulsen and U. Maass, Chem. Ber., 1981, 114, 346; A. B. Smith, B. H. Toder, R. E. Richmond and S. J. Branca, J. Am. Chem. Soc., 1984, 106, 4001; D. M. Hodgson, J. Witherington and B. A. Moloney, J. Chem. Soc., Perkin Trans. 1, 1994, 3373 (Tetrahedron: Asymmetry, 1994, 5, 337); J. Nokami, H. Matsuura, K. Nakasima and S. Shibata, Chem. Lett., 1994, 1071; H. Kapeller, C. Marschner, M. Weissenbacher and H. Griengl, Tetrahedron, 1998, 54, 1439; S. M. Siddiqi, X. Chen and S. W. Schneller, Nucleosides Nucleotides, 1993, 12, 267.
2. S. M. Roberts and K. A. Shoberu, J. Chem. Soc., Perkin Trans. 1, 1991, 2605; C. T. Evans, S. M. Roberts, K. A. Shoberu and A. G. Sutherland, J. Chem. Soc., Perkin Trans. 1., 1992, 589; S. M. Roberts and K. A. Shoberu, J. Chem. Soc., Perkin Trans. 1., 1992, 2419 for a full review of synthetic approaches to cyclopentyl carbocyclic nucleosides see: M. T. Crimmins, Tetrahedron, 1998, 54, 9229.
3. E. A. Saville-Jones, S. D. Lindell, N. S. Jennings, J. C. Head and M. J. Ford, J. Chem. Soc., Perkin Trans. 1, 1991, 2603.
4. D. R. Deardor, R. G. Linde, A. M. Martin and M. J. Shulman, J. Org. Chem., 1989, 54, 2759.
5. J. V. Barkley, A. Dhanda, L. J. S. Knutsen, M.-B. Nielsen, S. M. Roberts and D. R. Varley, Chem. Commun., 1998, 1117.
6. Racemic materials were used in this study; however the optically active compounds are readily available, R. McCague, R. A. MacKeith, H. F. Olivo, S. M. Roberts, S. J. C. Taylor and H. Xiong, Bioorg. Med. Chem., 1994, 2, 387 for alternative methods of preparation of optically active hydroxylactone 6 see S. Kudis and G. Helmchen, Tetrahedron, 1998, 54, 10449; F. Burlina, P. Clivio, J.-L. Fourrey, C. Riche and M. Thomas, Tetrahedron Lett., 1994, 35, 8151; N. Gathergood and K. A. Jørgensen, Chem. Commun., 1999, 1869.
7. B. M. Trost, R. Madsen, S. G. Guile and A. E. H. Elia, Angew. Chem., Int. Ed. Engl., 1996, 35, 1569; B. M. Trost, G.-H. Kuo and T. Benneche, J. Am. Chem. Soc., 1988, 110, 621.
8. B. M. Dominguez and P. M. Cullis, Tetrahedron Lett., 1999, 40, 5783.
9. N. Katagiri, Y. Ito, K. Kitano, A. Toyota and C. Kaneko, Chem. Pharm. Bull., 1994, 42, 2653.
10. G. Bullucci, G. Berti, G. Ingrosso and E. Mastrorilli, Tetrahedron Lett., 1973, 3911; R. Rodebaugh and B. Fraser-Reid, J. Am. Chem. Soc., 1994, 116, 3155.
11. A. S. Cieplak, J. Am. Chem. Soc., 1981, 103, 4540; A. S. Cieplak, B. D. Tait and C. R. Johnson, J. Am. Chem. Soc., 1989, 111, 8447.
12. F. Lang, D. J. Kassab and B. Ganem, Tetrahedron Lett., 1998, 39, 5903.